American Portfolios Advisors’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $3.86K | Hold |
1,650
| – | – | ﹤0.01% | 2921 |
|
|
2022
Q2 | $5K | Hold |
1,650
| – | – | ﹤0.01% | 2826 |
|
|
2022
Q1 | $11.2K | Hold |
1,650
| – | – | ﹤0.01% | 2638 |
|
|
2021
Q4 | $13.8K | Hold |
1,650
| – | – | ﹤0.01% | 2499 |
|
|
2021
Q3 | $12.3K | Hold |
1,650
| – | – | ﹤0.01% | 2482 |
|
|
2021
Q2 | $11.2K | Hold |
1,650
| – | – | ﹤0.01% | 2469 |
|
|
2021
Q1 | $16.9K | Sell |
1,650
-150
| -8% | -$1.54K | ﹤0.01% | 2156 |
|
|
2020
Q4 | $12.6K | Hold |
1,800
| – | – | ﹤0.01% | 2004 |
|
|
2020
Q3 | $14.7K | Sell |
1,800
-250
| -12% | -$2.04K | ﹤0.01% | 1835 |
|
|
2020
Q2 | $14.1K | Buy |
2,050
+450
| +28% | +$3.11K | ﹤0.01% | 1791 |
|
|
2020
Q1 | $7.6K | Buy |
1,600
+250
| +19% | +$1.19K | ﹤0.01% | 1919 |
|
|
2019
Q4 | $11.8K | Buy |
1,350
+750
| +125% | +$6.55K | ﹤0.01% | 1934 |
|
|
2019
Q3 | $2K | Hold |
600
| – | – | ﹤0.01% | 2515 |
|
|
2019
Q2 | $2.97K | Sell |
600
-500
| -45% | -$2.48K | ﹤0.01% | 2354 |
|
|
2019
Q1 | $6.82K | Hold |
1,100
| – | – | ﹤0.01% | 1971 |
|
|
2018
Q4 | $3.71K | Hold |
1,100
| – | – | ﹤0.01% | 1962 |
|
|
2018
Q3 | $7.15K | Hold |
1,100
| – | – | ﹤0.01% | 1871 |
|
|
2018
Q2 | $8.43K | Buy |
+1,100
| New | +$8.43K | ﹤0.01% | 1784 |
|